Back

Investigation of biological activities of Colocasia gigantea Hook.f. leaves and PASS prediction, in silico molecular docking with ADME/T analysis of its isolated bioactive compounds

Alam, S.; Emon, N. U.; A. Rashid, M.; Arman, M.; Rashedul Haque, M.

2020-05-19 bioinformatics
10.1101/2020.05.18.101113 bioRxiv
Show abstract

BackgroundColocasia gigantea is locally named as kochu and also better known due to its various healing power. This research is to investigate the antidiarrheal, antimicrobial, and antioxidant possibilities of the methanol soluble extract of Colocasia gigantea. MethodsAntidiarrheal investigation was performed by using in vivo castor oil induced diarrheal method where as in vitro antimicrobial and antioxidant investigation have been implemented by disc diffusion and DPPH scavenging method respectively. Moreover, in silico studies were followed by molecular docking analysis of several secondary metabolites were appraised with Schrodinger-Maestro v 11.1. ResultsThe induction of plant extract (200 and 400 mg/kg, b.w, p.o), the castor oil mediated diarrhea has been minimized 19.05 % (p < 0.05) and 42.86 % (p < 0.001) respectively. The methanolic extract of C. gigantea showed mild sensitivity against almost all the tested strains but it shows high consistency of phenolic content and furthermore yielded 67.68 g/mL of IC50 value in the DPPH test. The higher and lower binding affinity was shown in beta-amyrin and monoglyceryl stearic acid against the kappa-opioid receptor (PDB ID: 4DJH) with a docking score of -3.28 kcal/mol and -6.64 kcal/mol respectively. In the antimicrobial investigation, Penduletin and Beta-Amyrin showed the highest and lowest binding affinity against the selected receptors with the docking score of -8.27 kcal/mol and -1.66 kcal/mol respectively. ConclusionThe results of our scientific research reflect that the methanol soluble extract of C. gigantea is safe which may provide possibilities of alleviation of diarrhea and as a potential wellspring of antioxidants which can be considered as an alternate source for exploration of new medicinal products.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 7%
20.0%
2
Life Sciences
25 papers in training set
Top 0.1%
19.1%
3
Scientific Reports
3102 papers in training set
Top 16%
6.6%
4
Molecules
37 papers in training set
Top 0.2%
3.7%
5
PeerJ
261 papers in training set
Top 2%
3.7%
50% of probability mass above
6
Pharmaceuticals
33 papers in training set
Top 0.3%
2.7%
7
International Journal of Molecular Sciences
453 papers in training set
Top 6%
1.9%
8
RSC Advances
18 papers in training set
Top 0.4%
1.9%
9
Antioxidants
25 papers in training set
Top 0.2%
1.8%
10
Journal of Biomolecular Structure and Dynamics
43 papers in training set
Top 0.6%
1.7%
11
ACS Omega
90 papers in training set
Top 2%
1.7%
12
Plants
39 papers in training set
Top 1%
1.4%
13
Journal of Medical Virology
137 papers in training set
Top 3%
1.4%
14
Bioscience Reports
25 papers in training set
Top 0.8%
1.3%
15
Gene
41 papers in training set
Top 2%
1.0%
16
Archives of Clinical and Biomedical Research
28 papers in training set
Top 2%
0.9%
17
BMC Cardiovascular Disorders
14 papers in training set
Top 1%
0.8%
18
Heliyon
146 papers in training set
Top 5%
0.8%
19
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%
20
Food Chemistry
12 papers in training set
Top 0.4%
0.8%
21
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.8%
22
Gigabyte
60 papers in training set
Top 2%
0.7%
23
Journal of Translational Medicine
46 papers in training set
Top 3%
0.7%
24
Gene Reports
13 papers in training set
Top 0.8%
0.7%
25
BMC Microbiology
35 papers in training set
Top 2%
0.7%
26
Antibiotics
32 papers in training set
Top 2%
0.5%
27
Genomics
60 papers in training set
Top 3%
0.5%
28
Biochemical and Biophysical Research Communications
78 papers in training set
Top 3%
0.5%